한글목차

경카테터 심장판막 시장은 2025년에는 59억 3,000만 달러, 2032년에는 147억 5,000만 달러에 이르고, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 13.9%를 나타낼 전망입니다.

경카테터 심장판막 이식은 심장 판막증(VHD) 치료를 위해 생체 인공 판막으로 손상된 심장 판막을 복구하는 저 침습 심장 수술입니다. 전통적인 개심술을 대체하는 접근법이며 특히 위험이 매우 높은 환자에게 권장됩니다. 대동맥판은 왼쪽 하단 심실(좌심실)과 신체의 주동맥(대동맥) 사이에 있습니다. 밸브가 제대로 열리지 않으면 심장에서 몸으로의 혈류가 감소합니다. 경카테터 대동맥 판막 치환술(TAVR)은 증후성 대동맥 판막 협착증을 앓고 있으며, 표준 판막 치환술의 위험이 높은 사람의 치료를 위해 미국 FDA에 의해 승인되었습니다. TAVR은 혈류를 회복시키고 흉통, 호흡 곤란, 실신, 피로와 같은 대동맥 판막 협착증의 징후와 증상을 완화하는 데 도움이 됩니다. TAVR은 수술 대동맥 판막 치환술(개심술)으로 인한 합병증의 위험이있는 사람의 선택이 될 수 있습니다. 낮은 침습 수술에 대한 수요 증가는 예측 기간 동안 경카테터 심장판막 세계 시장의 성장을 뒷받침할 것으로 예측됩니다.

시장 역학

제품 포트폴리오를 확대하기 위해 시장의 주요 기업에 의한 인수와 같은 무기적 성장 전략의 채택이 증가하고 있으며 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2020년 6월 의료기기 제조업체인 SMT는 구조적 심장 의료기기인 Vascular Concepts를 인수하여 시장에 진입했다고 발표했습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계 경카테터 심장판막 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025년-2032년 시장 규모와 연간 평균 성장률(CAGR%)을 제공합니다.
• 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
• 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계의 경카테터 심장판막 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰은 마케팅 담당자와 기업 경영진이 미래 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 기반으로 의사 결정을 내릴 수 있도록 합니다.
• 경카테터 심장판막 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 시장 진출기업, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로합니다.
• 이해관계자는 세계 경카테터 심장판막 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 시장 기회
• 영향 분석
• 주요 하이라이트
• 제품 발매
• 기술의 진보
• PEST 분석
• 규제 시나리오
• 합병과 인수

제4장 세계의 경카테터 심장판막 시장, 제품 및 서비스별, 2020년-2032년

• TAVR
• TMVR

제5장 세계의 경카테터 심장판막 시장, 배송 시스템별, 2020년-2032년

• Transfemoral Approach
• Transapical Approach
• Transaortic Approach

제6장 세계의 경카테터 심장판막 시장, 최종 사용자별, 2020년-2032년

• 병원
• 외래수술센터(ASC)
• 심장 카테터 검사실
• 기타(전문센터 등)

제7장 세계의 경 카테터 심장변 시장, 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제8장 경쟁 구도

• Edwards Lifesciences Corporation
• Medtronic
• Boston Scientific Corporation
• Abbott
• JenaValve Technology
• SYMETIS
• Braile Biomedica
• CryoLife, Inc.
• Shockwave Medical Inc.
• Venus Medtech(Hangzhou) Inc.

제9장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Transcatheter Heart Valve Market is estimated to be valued at USD 5.93 Bn in 2025 and is expected to reach USD 14.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2032.

Transcatheter heart valve implantation is a minimally-invasive heart procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. The aortic valve is located between the left lower heart chamber (left ventricle) and the body's main artery (aorta). If the valve does not open correctly, blood flow from the heart to the body is reduced. Transcatheter aortic valve replacement (TAVR) is approved by the U.S. FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. TAVR can help restore blood flow and reduce the signs and symptoms of aortic valve stenosis - such as chest pain, shortness of breath, fainting and fatigue. TAVR may be an option for people who are at risk of complications from surgical aortic valve replacement (open-heart surgery). Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2020, SMT, a manufacturer of medical equipment, announced that it has acquired structural heart medical device firm Vascular Concepts, to enter into the market.

Key features of the study

• This report provides in-depth analysis of the global transcatheter heart valve market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global transcatheter heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study are Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife, Inc., Shockwave Medical Inc., Venus Medtech (Hangzhou) Inc.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global transcatheter heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter heart valve market.

Market Segmentation

• Global Transcatheter Heart Valve Market, By Product Type
  • TAVR
  • TMVR
• Global Transcatheter Heart Valve Market, By Delivery Systems
  • Transfemoral Approach
  • Transapical Approach
  • Transaortic Approach
• Global Transcatheter Heart Valve Market, By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratory
  • Other (Specialty Center, etc.)
• Global Transcatheter Heart Valve Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
  • Edwards Lifesciences Corporation
  • Medtronic
  • Boston Scientific Corporation
  • Abbott, JenaValve Technology
  • SYMETIS
  • Braile Biomedica
  • CryoLife, Inc.
  • Shockwave Medical Inc.
  • Venus Medtech (Hangzhou) Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product and Services
  • Market Snapshot, By Delivery Systems
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product Launch
• Technological Advancements
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Transcatheter Heart Valve Market, By Product and Services, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• TAVR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• TMVR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Transcatheter Heart Valve Market, By Delivery Systems, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Transfemoral Approach
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Transapical Approach
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Transaortic Approach
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Transcatheter Heart Valve Market, By End User, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Center
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiac Catheterization Laboratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Specialty Center, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Transcatheter Heart Valve Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Edwards Lifesciences Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• JenaValve Technology
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SYMETIS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Braile Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CryoLife, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Shockwave Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Venus Medtech (Hangzhou) Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us